Dirk W. Kirsten
Fortuna: 573 730 $ al 31/05/2026
Fortuna: 573 730 $ al 31/05/2026
Dirk W.
Kirsten worked as Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004.
From 2004 to 2008, worked as Group Treasurer at Syngenta AG.
From 2008 to 2013, worked as Chief Financial Officer at Nobel Biocare Holding AG.
From 2021 to 2026, worked as Chief Financial Officer at Medartis Holding AG.
Dr. Kirsten earned a doctorate from Universität zu Köln.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDARTIS HOLDING AG 0,04 % | 31/12/2025 | 5.762 ( 0,04 % ) | 573 730 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| MEDARTIS HOLDING AG | Director Financiero/CFO | 01/01/2026 |
| NOBEL BIOCARE HOLDING AG | Director Financiero/CFO | 01/01/2013 |
| SYNGENTA | Treasurer | 01/01/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Syngenta AG
Syngenta AG Information Technology ServicesTechnology Services Develops technologies and farming practices | Technology Services |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medartis Holding AG
Medartis Holding AG Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.